Delivery Order SPE2DB24D2101-SPE2DB25FKPSY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) valued at $17,968.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 29, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $71,873.56 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on September 29, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on August 29, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, represents a non-competitive, competitively awarded contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count supply) on August 26, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $35,936.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on September 18, 2025, with an ultimate completion date of October 9, 2025. The award is unclassified as a set-aside contract and represents a competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $35,936.78 delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Welireg 40 mg, a pharmaceutical product, with performance in Conshohocken, Pennsylvania and completion targeted for September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count packaging) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp was awarded a $17,968.39 delivery order by the Defense Logistics Agency on August 21, 2025, for the supply of Welireg 40 mg tablets (90-count units). This is a firm fixed price contract with no set-aside designation, competitively awarded under an open solicitation process. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is issued as a child contract under...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPSYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count) valued at $35,936.78 on September 18, 2025. This firm fixed-price delivery order, which is not subject to any set-aside designation, is scheduled for completion by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and a critical federal healthcare vendor, particularly for military and veteran medical supply needs. This delivery order is issued under the company's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical support globally. The IDC serves as a flexible vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 9/18/25 |